Hence, it warrants future testing of NRG1 treatment in other AD models, including the single humanized APP mutation knock-in AD mouse model47 and the triple transgenic mice that display both plaque and tangle pathology48. The gene discussed is NRG1; the disease is Alzheimer disease.